We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 160.00
Bid: 158.60
Ask: 159.80
Change: 0.00 (0.00%)
Spread: 1.20 (0.757%)
Open: 160.00
High: 160.00
Low: 160.00
Prev. Close: 160.00
FORT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Bison Manufacturing Ltd

28 Jul 2017 07:00

RNS Number : 3528M
Forterra plc
28 July 2017
 

28 July 2017

 

Forterra plc

Acquisition of the trade and assets of Bison Manufacturing Ltd

 

Forterra plc ("Forterra"), a leading UK producer of manufactured masonry products, announces that it has entered into an agreement to acquire the trade and assets of Bison Manufacturing Ltd ("Bison") from Laing O'Rourke plc ("Laing O'Rourke") for £20m. The acquisition will be funded from the Group's existing cash balances and is expected to complete in Q3 2017. Bison is the UK market leading manufacturer of hollowcore precast concrete flooring with a highly automated manufacturing facility located at Swadlincote, Derbyshire, which was opened in 2006.

 

This acquisition provides a unique and immediate opportunity for Forterra to take a leadership position in the UK precast concrete market whilst also expanding its currently capacity-constrained business. It also enables the Group to take advantage of the growing demand for these products in the residential, commercial and infrastructure markets, which are underpinned by Government initiatives to tackle the country's housing deficit and improve infrastructure. The Swadlincote plant is the largest and most technically advanced hollowcore manufacturing facility in the UK. In addition, the site includes a specialist precast facility capable of producing a wide range of bespoke precast concrete products. Forterra management estimate that it would cost in excess of £35m to replicate these assets on a greenfield site. Furthermore, the Bison brand is highly respected and valued in the precast market.

 

The Swadlincote plant has been operating at little more than 50% capacity utilisation. The acquisition will allow Forterra to expand its own precast concrete business to enable increased sales across our range of concrete product whilst benefiting from production efficiencies and economies of scale as the utilisation of the Swadlincote facility is substantially increased.

 

The acquisition also provides an opportunity to partner with Laing O'Rourke, a leading innovator and pioneer in off-site construction methods, and includes a five year commercial agreement for Forterra to supply hollowcore and other precast products to Laing O'Rourke.

 

The acquisition constitutes a Class 2 transaction for the purposes of the UK Financial Conduct Authority's Listing Rules. The gross assets that are subject to the transaction relate purely to tangible fixed assets and inventory at the Swadlincote site and had a net book value in the financial statements of the seller of £10.0 million at 31 March 2017. Revenue attributable to those assets was £22.8 million for the year to 31 March 2017, and the loss (at EBITDA level) attributable to those assets was £1.1 million.

 

Following completion, Forterra expects to generate a return on its investment in excess of its cost of capital by 2019 through efficiency improvements, proposed consolidation of production between sites and leveraging procurement synergies.

 

Stephen Harrison, Chief Executive, commented:

 

"The acquisition is a unique opportunity to transform Forterra's precast business in terms of scale and capability. We are acquiring well invested assets whilst at the same time solving the capacity constraints on growth within our own business. We gain a well-respected brand and will attain a market leading position as we look to grow the combined business.

 

"We are confident that the acquisition will create value for our shareholders".

 

Forterra will announce half year results for the six months ended 30 June 2017 on 1 August 2017.

 

 

Enquiries

Forterra plc:

+44 (0) 1604 707 600

Stephen Harrison (CEO)

Shatish Dasani (CFO)

FTI Consulting:

+44 (0) 20 3727 1340

Richard Mountain

Nick Hasell

 

Further information relating to the Company and its group can be found at www.forterraplc.co.uk

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQRRMATMBITBLR
Date   Source Headline
15th Apr 20241:46 pmRNSAnnual Report & Accounts 2023 & Notice of AGM 2024
12th Apr 202412:09 pmRNSDirector/PDMR Shareholding
9th Apr 20244:22 pmRNSDirector/PDMR Shareholding
9th Apr 20244:19 pmRNSDirector/PDMR Shareholding
3rd Apr 20242:19 pmRNSDirector/PDMR Shareholding
27th Mar 20244:44 pmRNSDirector/PDMR Shareholding
25th Jan 202412:27 pmRNSDirector Declaration
24th Jan 20247:19 amRNSProgressive publish new research
24th Jan 20247:00 amRNS2023 Trading Update
23rd Jan 20247:00 amRNSHolding(s) in Company
8th Dec 20237:00 amRNSDirector Declaration
9th Nov 20237:00 amRNSAppointment of Joint Corporate Broker
20th Oct 20236:05 pmRNSDirector/PDMR Shareholding
11th Oct 20237:00 amRNSQ3 Trading Update
5th Oct 20235:04 pmRNSGrant of Options under 2023 SAYE Scheme
11th Sep 20237:00 amRNSHolding(s) in Company
1st Sep 20235:46 pmRNSHolding(s) in Company
23rd Aug 20233:59 pmRNSHolding(s) in Company
27th Jul 20237:00 amRNSSix months ended 30 June 2023
11th Jul 20237:00 amRNSPost close half year trading update
5th Jul 202312:39 pmRNSEmployee Benefit Trust Share Purchase
30th Jun 20231:51 pmRNSHolding(s) in Company
6th Jun 202312:57 pmRNSEmployee Benefit Trust Share Purchase
23rd May 20232:22 pmRNSAnnual General Meeting 2023 Results
18th May 202312:12 pmRNSProgressive publish new research
16th May 20237:00 amRNSPre-AGM trading update
5th May 20234:39 pmRNSDirector/PDMR Shareholding
4th May 20239:00 amRNSEmployee Benefit Trust Share Purchase
25th Apr 20237:00 amRNSNotification of Board Changes
11th Apr 20234:15 pmRNSPCA Shareholdings
4th Apr 20231:12 pmRNSEmployee Benefit Trust Share Purchase
3rd Apr 20232:03 pmRNSGrant under Performance Share Plan
29th Mar 202310:21 amRNSAnnual Report & Accounts 2022 & Notice of AGM 2023
16th Mar 20235:28 pmRNSGrant under Deferred Annual Bonus Plan
10th Mar 20239:18 amRNSProgressive publishes new research
9th Mar 20237:02 amRNSAppointment of Independent Non-Executive Director
9th Mar 20237:00 amRNSFull Year Results
3rd Mar 20232:18 pmRNSEmployee Benefit Trust Share Purchase
3rd Feb 202310:13 amRNSEmployee Benefit Trust Share Purchase
1st Feb 20238:18 amRNSDirector Declaration
25th Jan 20237:00 amRNSTrading Update
5th Jan 20233:12 pmRNSEmployee Benefit Trust Share Purchase
14th Dec 20225:10 pmRNSEmployee Benefit Trust Share Purchase
8th Dec 20227:00 amRNSHolding(s) in Company
2nd Dec 20224:10 pmRNSEmployee Benefit Trust Share Purchase
22nd Nov 20227:54 amRNSProgressive publishes new research
22nd Nov 20227:01 amRNSAppointment of Chief Executive Officer
22nd Nov 20227:00 amRNSTrading Update
4th Nov 20222:50 pmRNSEmployee Benefit Trust Share Purchase
2nd Nov 20228:45 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.